Robert Califf, as FDA Commissioner, is actively promoting the agenda of the Fourth Industrial Revolution in healthcare by creating loopholes for technologies like brain machine interfaces and neuromodulation devices.
Kaliff's involvement with Google Health reveals the growing collaboration between big tech and healthcare, aiming to revolutionize clinical trials and generate real-world evidence using personal and digital data collected from individuals.
Kaliff believes in leveraging data from electronic health records, wearable devices, and other personal data sources to generate evidence, cutting costs, and accelerating the development and approval process for new medical devices and drugs.
Deep dives
Robert Kaliff's background and conflicts of interest
Robert Kaliff, the current FDA commissioner, has a background in pharmaceutical and biotechnology industries and has long-standing ties to big pharma. His previous role as the top strategist for Google's health focus subsidiary, Verily Life Sciences, reveals his involvement in the fourth industrial revolution in healthcare. Kaliff is an advocate for merging physical, digital, and biological aspects of human existence, similar to the concept of transhumanism. As FDA commissioner, he has been creating regulatory loopholes for technologies like brain machine interfaces and neuromodulation devices, pushing the agenda of the fourth industrial revolution in healthcare.
Kaliff's role at Google and his ties to big tech
After leaving his first stint as FDA commissioner, Kaliff joined Google as their head of health strategy and policy. During his time at Google, he spearheaded Project Baseline, a large-scale study aiming to map human health. This study involved wearable devices and passive collection of patient data, such as electronic health records. Kaliff's involvement with Google Health highlights the growing collaboration between big tech and healthcare. This partnership aims to revolutionize clinical trials and generate real-world evidence using a vast amount of personal and digital data collected from individuals.
Kaliff's support for the Fourth Industrial Revolution
Kaliff has openly expressed his support for the concept of the Fourth Industrial Revolution (4IR). He shares the vision put forth by the World Economic Forum and its Chairman Klaus Schwab. The 4IR in healthcare aims to merge physical, digital, and biological aspects, ultimately leading to transhumanism. As FDA commissioner, Kaliff has been actively promoting the 4IR agenda by creating regulations that support the development and adoption of technologies like brain machine interfaces, gene therapies, and wearables. This push towards the 4IR raises concerns about privacy, surveillance, and the impact on individual autonomy.
Kaliff's focus on real-world evidence and remote clinical trials
One of Kaliff's key areas of focus is the use of real-world evidence in clinical trials. He believes that traditional randomized controlled trials are expensive and take time. Instead, Kaliff advocates for leveraging data collected from sources like electronic health records, wearable devices, and other personal data to generate evidence. This approach aims to cut costs and accelerate the development and approval process for new medical devices and drugs. Kaliff's emphasis on remote clinical trials, utilizing digital data instead of in-person monitoring, further aligns with the agenda of integrating technology into healthcare.
The implications of Kaliff's regulatory approach and the surveillance state
The rise of the fourth industrial revolution in healthcare, coupled with Kaliff's leadership at the FDA, raises concerns about the growing surveillance state and the potential threats to individual privacy and autonomy. The increasing collaboration between big tech and healthcare poses risks of data exploitation and manipulation. Moreover, Kaliff's support for combating 'misinformation' and the use of artificial intelligence for flagging 'probable cause' raises concerns about the erosion of civil liberties and the potential abuse of power. It is crucial for individuals to be aware of these developments and engage in discussions regarding the ethical implications of merging technology and healthcare.
In this episode, Whitney is joined by Maddie Bannon to discuss FDA Commissioner Robert Califf and his role in removing regulatory obstacles for the "healthcare" related wearable, implantable devices and other emerging technologies seen as crucial to the advance of the 4th Industrial Revolution.
